BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25273336)

  • 1. IVGTT-based simple assessment of glucose tolerance in the Zucker fatty rat: Validation against minimal models.
    Morettini M; Faelli E; Perasso L; Fioretti S; Burattini L; Ruggeri P; Di Nardo F
    PLoS One; 2017; 12(3):e0173200. PubMed ID: 28264067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Skeletal Muscle and Whole-Body Insulin Sensitivity Using NMR-Metabolomic Profiling.
    Klén R; Honka MJ; Hannukainen JC; Huovinen V; Bucci M; Latva-Rasku A; Venäläinen MS; Kalliokoski KK; Virtanen KA; Lautamäki R; Iozzo P; Elo LL; Nuutila P
    J Endocr Soc; 2020 Apr; 4(4):bvaa026. PubMed ID: 32232183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special features on insulin resistance, metabolic syndrome and vascular complications in hypopituitary patients.
    Garmes HM
    Rev Endocr Metab Disord; 2024 Jun; 25(3):489-504. PubMed ID: 38270844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Carotid Intima-media Thickness and Its Association with Carbohydrate Metabolism and Adipocytokines in Children Treated with Recombinant Growth Hormone.
    Saygılı S; Kocaağa M; Kaya G; Şükür M; Baş F; Poyrazoğlu Ş; Bundak R; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2023 Feb; 15(1):69-80. PubMed ID: 36416456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signaling in the whole spectrum of GH deficiency.
    Garmes HM; Castillo AR
    Arch Endocrinol Metab; 2019; 63(6):582-591. PubMed ID: 31939483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Metabolism Evaluated by Glycated Hemoglobin and Insulin Sensitivity Indices in Children Treated with Recombinant Human Growth Hormone.
    Pellegrin MC; Michelon D; Faleschini E; Germani C; Barbi E; Tornese G
    J Clin Res Pediatr Endocrinol; 2019 Nov; 11(4):350-357. PubMed ID: 30819016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose Metabolism in Children With Growth Hormone Deficiency.
    Ciresi A; Giordano C
    Front Endocrinol (Lausanne); 2018; 9():321. PubMed ID: 29942285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic outcomes of growth hormone treatment in children are gender specific.
    Ciresi A; Radellini S; Guarnotta V; Mineo MG; Giordano C
    Endocr Connect; 2018 Jul; 7(7):879-887. PubMed ID: 29925523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose homeostasis in GHD children during long-term replacement therapy: a case-control study.
    Capalbo D; Esposito A; Improda N; Wasniewska MG; Di Mase R; De Luca F; Bruzzese D; Salerno M
    Endocrine; 2018 Mar; 59(3):643-650. PubMed ID: 28875423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency.
    Ciresi A; Radellini S; Vigneri E; Guarnotta V; Bianco J; Mineo MG; Giordano C
    J Endocrinol Invest; 2018 Mar; 41(3):333-342. PubMed ID: 28819906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of the Growth Hormone-Insulin-Like Growth Factor (GH-IGF) Axis: A Treatment Strategy to Reverse the Effects of Early Life Developmental Programming.
    Reynolds CM; Perry JK; Vickers MH
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28786951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More Favorable Metabolic Impact of Three-Times-Weekly versus Daily Growth Hormone Treatment in Naïve GH-Deficient Children.
    Ciresi A; Cicciò F; Radellini S; Guarnotta V; Calcaterra AM; Giordano C
    Int J Endocrinol; 2017; 2017():8469680. PubMed ID: 28634491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children.
    Ciresi A; Pizzolanti G; Leotta M; Guarnotta V; Teresi G; Giordano C
    J Endocrinol Invest; 2016 Sep; 39(9):1023-30. PubMed ID: 27126309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA).
    Ciresi A; Cicciò F; Amato MC; Giordano C
    J Endocrinol Invest; 2015 Dec; 38(12):1301-7. PubMed ID: 26015317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment.
    Ciresi A; Amato MC; Giordano C
    J Endocrinol Invest; 2015 Mar; 38(3):351-9. PubMed ID: 25273336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency.
    Ciresi A; Giordano C
    J Endocrinol Invest; 2018 Jul; 41(7):789-797. PubMed ID: 29249018
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.